COMMUNIQUÉS West-GlobeNewswire

BioStem Technologies to Present at the Advanced Wound Care Summit in Boston on July 15, 2025, at 2:00 PM ET
10/07/2025
Jason Matuszewski, Chairman and CEO, to present BioStem’s current position in the chronic wound care market and key opportunities for growth POMPANO BEACH, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, [...]
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership
10/07/2025
Pioneering a New Era in Healthcare: AI-Driven Innovation Unlocks Transformative Therapies and Drives Path to $50M Valuation SEATTLE, July 10, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, LLC, a wholly owned [...]
Radical Catheter Technologies’ 8F Neurovascular Guide Catheter Demonstrates Outstanding Clinical Performance in Initial Cases
10/07/2025
Company to Showcase Progress on Radical Catheter Portfolio and Best-in-Class Ribbon Technology Platform at Society of Neurointerventional Surgery Annual Meeting LOS GATOS, calif., July 10, 2025 (GLOBE NEWSWIRE) -- [...]
Privia Health to Report Second Quarter 2025 Results on Thursday, August 7
10/07/2025
ARLINGTON, Va., July 10, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its second-quarter and six-month periods ended June 30, 2025 [...]
MMI’s Symani® System Redefines Robotic Microsurgery Again with First-Ever Dissection and Digital Surgery Capabilities
10/07/2025
First-in-human case marks clinical debut of NanoWrist® dissection tools and Synaptix™ digital surgery platform, enabling greater robotic precision across more of the microsurgical procedure JACKSONVILLE, Fla., July 10, [...]
Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause
10/07/2025
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a new partnership with ŌURA , maker of the world’s leading smart [...]
Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock
10/07/2025
REDWOOD CITY, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (Nasdaq: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today [...]
Epilepsy Foundation of America Welcomes Accomplished Communications Executive to National Board of Directors
10/07/2025
BOWIE, Md., July 10, 2025 (GLOBE NEWSWIRE) -- The Epilepsy Foundation of America (EFA) is proud to announce the appointment of Daryl Drabinsky, distinguished communications and corporate affairs executive, to its [...]
Vessel Sealer Curved receives FDA clearance
10/07/2025
Intuitive’s latest advanced energy instrument features a unique curved tip for enhanced precision SUNNYVALE, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally [...]
Testosterone Booster for Men: RITI Adds Ashwagandha to its Testosterone Support Formula
10/07/2025
Dover, Delaware, July 10, 2025 (GLOBE NEWSWIRE) -- RITI announced today that its flagship testosterone booster for men now features 150 mg of KSM-66® Ashwagandha root extract, standardized to 2.5 % withanolides, per [...]
Ascentage Pharma Announces Its Novel Bcl-2 Inhibitor Lisaftoclax Approved by China NMPA, Ushering in a New Era for the Treatment of CLL/SLL
10/07/2025
ROCKVILLE, Md. and SUZHOU, China, July 10, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that [...]
U.S. Oral Surgery Management Enters Utah
10/07/2025
Secures New Partnership with Hopkin Oral Surgery IRVING, Texas, July 10, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) – a management services organization that exclusively serves premier oral and [...]
AscellaHealth Launches Q2 2025 Specialty & Rare Pipeline Digest™ to Support Stakeholders Navigating Specialty Drug Growth
10/07/2025
BERWYN, Pa., July 10, 2025 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces the release of its Q2 2025 Specialty & [...]
Annette Slyman brings Global Marketing, Commercial and Operational Experience to Galacxia, Inc. as Chief Operating Officer of Life Backup Plan App
10/07/2025
Seasoned Strategy & Communications Executive Joins Leadership Team Aliso Viejo, CA, July 10, 2025 (GLOBE NEWSWIRE) -- Galacxia, Inc., creator of the Life Backup Plan app, proudly announces the appointment of Annette [...]
Angelini Ventures Co-leads CHF 79 Million (€84 Million) Series B Financing of NUCLIDIUM to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform
10/07/2025
- Regina Hodits, Managing Director to join NUCLIDIUM’s Board of Directors Rome, Italy, 10 th July 2025 – Angelini Ventures, the corporate venture firm of Angelini Industries focused on investing in companies developing [...]
Soleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025
10/07/2025
REDWOOD CITY, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (Nasdaq: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today [...]
Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock
10/07/2025
REDWOOD CITY, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (Nasdaq:SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today [...]
Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
10/07/2025
BOSTON, July 10, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare [...]
Pharvaris Updates Timing of Topline Data Announcement for RAPIDe-3 Pivotal Phase 3 Study to the Fourth Quarter of 2025
10/07/2025
Company expects to submit deucrictibant IR capsule NDA to the U.S. FDA for the on-demand treatment of HAE attacks in 1H2026 ZUG, Switzerland, July 10, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage [...]

Pages